First Horizon Advisors, Inc. Axogen, Inc. Transaction History
First Horizon Advisors, Inc.
- $3.81 Billion
- Q2 2025
A detailed history of First Horizon Advisors, Inc. transactions in Axogen, Inc. stock. As of the latest transaction made, First Horizon Advisors, Inc. holds 1,028 shares of AXGN stock, worth $25,093. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,028
Previous 1,028
-0.0%
Holding current value
$25,093
Previous $19,000
42.11%
% of portfolio
0.0%
Previous 0.0%
Shares
11 transactions
Others Institutions Holding AXGN
# of Institutions
177Shares Held
41.7MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$111 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$79.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.68MShares$65.4 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$61.3 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$47.1 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $1.03B
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...